DEUTSCHE BANK AG\ - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$55,000
-11.3%
25,416
-8.2%
0.00%
Q4 2020$62,000
+14.8%
27,678
+37.0%
0.00%
Q3 2020$54,000
-3.6%
20,204
+9.8%
0.00%
Q2 2020$56,000
+100.0%
18,408
+33.1%
0.00%
Q1 2020$28,000
-53.3%
13,826
-35.1%
0.00%
Q4 2019$60,000
+42.9%
21,290
+79.1%
0.00%
Q3 2019$42,000
-66.1%
11,884
-60.6%
0.00%
Q2 2019$124,000
-59.9%
30,174
-50.3%
0.00%
Q1 2019$309,00060,754
+3037600.0%
0.00%
Q3 2018$0
-100.0%
2
-99.9%
0.00%
Q2 2018$16,000
+33.3%
2,602
+0.1%
0.00%
Q1 2018$12,0002,600
+129900.0%
0.00%
Q4 2017$020.0%0.00%
Q3 2017$02
-98.0%
0.00%
Q2 2017$0102
+5000.0%
0.00%
Q1 2017$020.0%0.00%
Q4 2016$020.0%0.00%
Q3 2016$02
-84.6%
0.00%
Q2 2016$0
-100.0%
13
-99.1%
0.00%
Q1 2016$2,000
-75.0%
1,511
-72.5%
0.00%
Q4 2015$8,000
+166.7%
5,486
+265.7%
0.00%
Q3 2015$3,000
-66.7%
1,500
-56.6%
0.00%
Q2 2015$9,000
+12.5%
3,458
+33.5%
0.00%
Q1 2015$8,000
-92.7%
2,591
-91.8%
0.00%
Q4 2014$109,000
-31.0%
31,510
-0.5%
0.00%
Q3 2014$158,000
-63.7%
31,673
+0.3%
0.00%
Q2 2014$435,000
+806.2%
31,587
+904.0%
0.00%
Q1 2014$48,0003,1460.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders